Sven Fraterman

Sven Fraterman currently serves as Managing Director and Partner at Boston Consulting Group, focusing on research and development, product launches, and organizational design since February 2017. Prior experience includes roles at Sandoz Pharmaceuticals AG, where responsibilities included Head of BU Hospital for Oncology & Biosimilars and Director of Strategic Planning, as well as positions at Boehringer Ingelheim, overseeing commercial project teams in oncology and cardio-metabolism. Sven's career began at McKinsey & Company as an Engagement Manager, leading strategic projects for major pharmaceutical brands. Sven also holds a PhD in Biochemistry from the European Molecular Biology Laboratory and a B.Sc. in Business Administration and Economics from FernUniversität in Hagen.